
    
      This randomized, double-blind, placebo-controlled, parallel-group study will included 120
      children <3 years old with â‰¥3 episodes of wheezing during the previous year. They will
      receive active treatment or placebo for six months. The main outcome will be the number of
      wheezing attacks during one year. Other outcomes were duration and severity of wheezing
      attacks , symptom and medication scores, and use of health resources.
    
  